Stock listing

Neurogene Inc.

Selected listing: UU8 · DUS · EUR · DE

Neurogene Inc. (Dusseldorf:UU8), Health Technology. Latest release Oct 5, 2026: Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

UU8:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:UU8
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Dusseldorf
Currency: EUR

Latest news from Neurogene Inc.

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 5, 2026

Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 4, 2026

Neurogene to Participate in H.C. Wainwright 28th Annual Global Investment Conference

September 8, 2026

Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates

August 11, 2026

Neurogene Inc. Announces Pricing of $125 Million Public Offering

July 1, 2026

All Neurogene Inc. news →

Events

Replays

Neoleukin Therapeutics, Inc. (NLTX) Q2 2022 Earnings Call
Tue, Aug 09, 2022 · 04:30 PM ET
Watch
Neoleukin Therapeutics, Inc. (NLTX) Q4 2021 Earnings Call
Tue, Mar 01, 2022 · 04:30 PM ET
Watch

Research Neurogene Inc.

Neurogene Inc. company profile

View the public company page for Neurogene Inc. on 6ix.

Neurogene Inc. news

Read company news and market updates connected to Neurogene Inc..

Neurogene Inc. investor events

Find investor webinars, events, and replay context for Neurogene Inc..